|
|||||
|
|
MEK Inhibitor Binimetinib (MEK162) in Relapse and Refractory Acute Myeloid Leukemia: Results of a Phase I/II Study |
|
| Authors: | Abhishek Maiti Kiran Naqvi Tapan Kadia Gautam Borthakur Koichi Takahashi Prithviraj Bose Naval Daver Ami Patel Yesid Alvarado Maro Ohanian Courtney DiNardo Elias Jabbour Guillermo Garcia-Manero Hagop Kantarjian Farhad Ravandi |
| Affiliation: | 1. The University of Texas MD Anderson Cancer Center, Houston, Texas, United States |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |